Preferential loss of serotonin markers in caudate versus putamen in Parkinson's disease

ISSN： 1460-2156

Source： Brain, Vol.131, Iss.1, 2008-01, pp. : 120-131

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Dopamine release rather than content in the caudate putamen is associated with behavioral changes in the iron rat model of parkinson's disease

By Junxia X. Hong J. Wenfang C. Ming Q.

Experimental Neurology, Vol. 182, Iss. 2, 2003-08 ,pp. : 483-489

Elsevier

Access to resources Recommend Favorite

Bilateral caudate and putamen grafts of embryonic mesencephalic tissue treated with lazaroids in Parkinson's disease

By Brundin P.

Brain, Vol. 123, Iss. 7, 2000-07 ,pp. : 1380-1390

Oxford University Press

Access to resources Recommend Favorite

Diorthosubstituted Polychlorinated Biphenyls in Caudate Nucleus in Parkinson's Disease

By Corrigan F.M. Murray L. Wyatt C.L. Shore R.F.

Experimental Neurology, Vol. 150, Iss. 2, 1998-04 ,pp. : 339-342

Elsevier

Access to resources Recommend Favorite

Hypocretin (orexin) loss in Parkinson's disease

By Fronczek Rolf

Brain, Vol. 130, Iss. 6, 2007-06 ,pp. : 1577-1585

Oxford University Press

Access to resources Recommend Favorite

The subcortical anatomy of human spatial neglect: putamen, caudate nucleus and pulvinar

By Karnath H-O. Himmelbach M. Rorden C.

Brain, Vol. 125, Iss. 2, 2002-02 ,pp. : 350-360

Oxford University Press

Access to resources Recommend Favorite